{"id":"NCT00452452","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children","officialTitle":"A Phase 3 Open-label Trial Evaluating the Safety, Tolerability and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Older Infants and Children Who Are Naive to Previous Vaccination With Pneumococcal Conjugate Vaccine.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2007-03-27","resultsPosted":"2012-08-15","lastUpdate":"2012-08-15"},"enrollment":355,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent Pneumococcal Conjugate Vaccine","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent Pneumococcal conjugate vaccine (13vPnC) in older infants and children who have not previously been immunized with Pneumococcal vaccine.","primaryOutcome":{"measure":"Percentage of Participants Achieving Antibody Level ≥0.35μg/mL After Vaccination","timeFrame":"28 to 42 days after vaccination 3 for Group 1 (13 to <17 months of age), after vaccination 2 for Group 2 (14 to <26 months of age), and after vaccination 1 for Group 3 (26 to <73 months of age).","effectByArm":[{"arm":"13vPnC 7 to <12 Months of Age","deltaMin":100,"sd":null},{"arm":"13vPnC 12 to <24 Months of Age","deltaMin":100,"sd":null},{"arm":"13vPnC 24 to < 72 Months of Age","deltaMin":99.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"7 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["Poland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":90},"commonTop":["Erythema (any)","Erythema (Mild)","Induration (Any)","Tenderness (any)","Induration (mild)"]}}